Tag: In the News,Non-Small Cell Lung Cancer,blood-based cancer test,cancer diagnostics,cancer treatment,molecular diagnostic,oncology,personalized medicine,rocky radar

  “One data point doesn’t tell you very much in most cases,” comments David Brunel, CEO of Biodesix, a medical diagnostics company based in Broomfield, Colorado. This principle guides Biodesix’s approach to developing diagnostics which aim to identify a patient’s expected response to a particular therapeutic.